Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Radiology, Nuclear Medicine & Medical Imaging, oxygen mapping, tissue hypoxia, MRI, R-1, endogenous contrast, ELECTRON-PARAMAGNETIC-RESONANCE, TUMOR OXYGENATION, PARTIAL-PRESSURE, CANCER-THERAPY, DIABETIC FOOT, HYPOXIA, T1, QUANTIFICATION, FLOW, TIME, R1, Animals, Breast Neoplasms, Contrast Media, Female, Humans, Image Enhancement, Lipids, Magnetic Resonance Imaging, Mice, Monitoring, Physiologic, Neoplasms, Oximetry, Oxygen, Protons, Stroke, 0903 Biomedical Engineering, Nuclear Medicine & Medical Imaging, 4003 Biomedical engineering

Abstract:

PURPOSE: Because of its paramagnetic properties, oxygen may act as an endogenous magnetic resonance imaging contrast agent by changing proton relaxation rates. Changes in tissue oxygen concentrations have been shown to produce changes in relaxation rate R1 of water. The aim of the study was to improve the sensitivity of oxygen enhanced R1 imaging by exploiting the higher solubility of oxygen in lipids (as compared with water) to sensitively monitor changes in tissue oxygen levels by selectively measuring the R1 of lipids. METHODS: The method, with the acronym "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement), was applied in different mouse models of hypoxic processes on a 11.7 T magnetic resonance imaging system. MOBILE was compared with R*2, R1 of water, and with pO2 measurements (using electron paramagnetic resonance oximetry). MOBILE was also applied in the brain of healthy human volunteers exposed to an oxygen breathing challenge on a 3 T magnetic resonance imaging system. RESULTS: MOBILE was shown to be able to monitor changes in oxygenation in tumor, peripheral, liver, and brain tissues. The clinical translation was demonstrated in human volunteers. CONCLUSION: MOBILE arises as a promising noninvasive and sensitive tool for diagnosis and therapeutic guidance in disorders involving hypoxia.